Power calculations to select instruments for clinical trial secondary endpoints: A case study of instrument selection for post-traumatic stress symptoms in subjects with acute respiratory distress syndrome

Annals of the American Thoracic Society

Volumn 14, Issue 1, 2017, Pages 110-117

  Sjoding, Michael W ^a,b   Schoenfeld, David A ^c   Brown, Samuel M ^d   Hough, Catherine L ^e   Yealy, Donald M ^f   Moss, Marc ^g   Angus, Derek C ^h   Iwashyna, Theodore J ^a,i  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f Department of Emergency Medicine ^*  (United States)

^g UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁱ VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bias; Clinical trials; Critical care outcomes; Sensitivity; Specificity

Indexed keywords

CISATRACURIUM; ATRACURIUM BESILATE; NEUROMUSCULAR BLOCKING AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CALCULATION; CASE STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; CRITICAL CARE OUTCOME; DRUG MEGADOSE; FALSE POSITIVE RESULT; FOLLOW UP; HOSPITAL MORTALITY; HUMAN; IMPACT OF EVENTS SCALE; INTENSIVE CARE UNIT; MATHEMATICAL PARAMETERS; NEUROMUSCULAR BLOCKING; POSTTRAUMATIC STRESS DISORDER; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SELECTION BIAS; SENSITIVITY AND SPECIFICITY; STUDY DESIGN; TASK PERFORMANCE; VALIDATION STUDY; ANALOGS AND DERIVATIVES; ARTIFICIAL VENTILATION; INTENSIVE CARE; OUTCOME ASSESSMENT; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); UTILIZATION;

ATRACURIUM; CRITICAL CARE; HUMANS; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR BLOCKING AGENTS; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY; STRESS DISORDERS, POST-TRAUMATIC;

EID: 85008392802     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201608-585OC     Document Type: Article

References (18)

1. ClincialTrials.gov. Reevaluation of Systemic Early Neuromuscular Blockade (ROSE) [accessed 2015 Dec 1]. Available from: https:// clinicaltrials.gov/ct2/show/NCT02509078
2. Bienvenu OJ, Williams JB, Yang A, Hopkins RO, Needham DM. Posttraumatic stress disorder in survivors of acute lung injury: evaluating the Impact of Event Scale-Revised. Chest 2013;144:24-31.
3. Twigg E, Humphris G, Jones C, Bramwell R, Griffiths RD. Use of a screening questionnaire for post-traumatic stress disorder (PTSD) on a sample of UK ICU patients. Acta Anaesthesiol Scand 2008;52:202-208.
4. Stoll C, Kapfhammer HP, Rothenhäusler HB, Haller M, Briegel J, Schmidt M, Krauseneck T, Durst K, Schelling G. Sensitivity and specificity of a screening test to document traumatic experiences and to diagnose post-traumatic stress disorder in ARDS patients after intensive care treatment. Intensive Care Med 1999;25:697-704.
5. Jones C, Bäckman C, Capuzzo M, Flaatten H, Rylander C, Griffiths RD. Precipitants of post-traumatic stress disorder following intensive care: a hypothesis generating study of diversity in care. Intensive Care Med 2007;33:978-985.
6. Arnot-Smith J, Smith AF. Patient safety incidents involving neuromuscular blockade: analysis of the UK National Reporting and Learning System data from 2006 to 2008. Anaesthesia 2010;65:1106-1113.
7. Leatherman JW, Fluegel WL, David WS, Davies SF, Iber C. Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med 1996;153:1686-1690.
8. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, Keane TM. The development of a Clinician-Administered PTSD Scale. J Trauma Stress 1995;8:75-90.
9. Parker AM, Sricharoenchai T, Raparla S, Schneck KW, Bienvenu OJ, Needham DM. Posttraumatic stress disorder in critical illness survivors: a metaanalysis. Crit Care Med 2015;43:1121-1129.
10. Jackson JC, Pandharipande PP, Girard TD, Brummel NE, Thompson JL, Hughes CG, Pun BT, Vasilevskis EE, Morandi A, Shintani AK, et al.; Bringing to light the Risk Factors And Incidence of Neuropsychological dysfunction in ICU survivors (BRAIN-ICU) study investigators. Depression, post-traumatic stress disorder, and functional disability in survivors of critical illness in the BRAIN-ICU study: a longitudinal cohort study. Lancet Respir Med 2014;2:369-379.
11. Shoukri MM. Measures of interobserver agreement. Boca Raton, FL: Chapman & Hall/CRC; 2004.
12. Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions. Hoboken, NJ: John Wiley and Sons; 2003.
13. Sjoding MW, Cooke CR, Iwashyna TJ, Hofer TP. Acute respiratory distress syndrome measurement error: potential effect on clinical study results. Ann Am Thorac Soc 2016;13:1123-1128.
14. Iwashyna TJ, Burke JF, Sussman JB, Prescott HC, Hayward RA, Angus DC. Implications of heterogeneity of treatment effect for reporting and analysis of randomized trials in critical care. Am J Respir Crit Care Med 2015;192:1045-1051.
15. Jutte JE, Needham DM, Pfoh ER, Bienvenu OJ. Psychometric evaluation of the Hospital Anxiety and Depression Scale 3 months after acute lung injury. J Crit Care 2015;30:793-798.
16. Pfoh ER, Chan KS, Dinglas VD, Girard TD, Jackson JC, Morris PE, Hough CL, Mendez-Tellez PA, Ely EW, Huang M, et al.; NIH NHLBI ARDS Network. Cognitive screening among acute respiratory failure survivors: a cross-sectional evaluation of the Mini-Mental State Examination. Crit Care 2015;19:220.
17. Chan KS, Pfoh ER, Denehy L, Elliott D, Holland AE, Dinglas VD, Needham DM. Construct validity and minimal important difference of 6-minute walk distance in survivors of acute respiratory failure. Chest 2015;147:1316-1326.
18. Cao J, Zhang S. Multiple comparison procedures. JAMA 2014;312: 543-544.